Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. 1992

I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
Department of Rheumatology, University Hospital, Leiden, The Netherlands.

OBJECTIVE To determine the occurrence of antineutrophil cytoplasmic antibodies (ANCA) and the specificity of these antibodies (Ab) in serum from patients with rheumatoid arthritis (RA) and patients with rheumatoid arthritis complicated by vasculitis (rheumatoid vasculitis [RV]). METHODS ANCA was detected with an indirect immunofluorescence test on ethanol-fixed granulocytes. Ab against the cytoplasmic antigens proteinase-3, elastase, lactoferrin (LF), and myeloperoxidase were measured by enzyme-linked immunosorbent assay. RESULTS ANCA were found in the serum of 43% of 49 patients with RV and in 36% of 50 patients with RA. Anti-LF Ab occurred more frequently in RV patients (45%) than in RA patients (4%), whereas reactivity against the other cytoplasmic antigens did not differe significantly between these groups. CONCLUSIONS Anti-LF Ab in serum of patients with RA may be useful in the diagnosis of vasculitis in RA.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
May 1990, Rheumatic diseases clinics of North America,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
January 1999, Advances in experimental medicine and biology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
October 1989, Clinical and experimental immunology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
January 2018, Ophthalmic plastic and reconstructive surgery,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
April 1999, The British journal of dermatology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
July 2010, Joint bone spine,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
April 2022, BMC nephrology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
January 2010, Clinical and experimental rheumatology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
January 1990, Scandinavian journal of rheumatology,
I E Coremans, and E C Hagen, and M R Daha, and F J van der Woude, and E A van der Voort, and C Kleijburg-van der Keur, and F C Breedveld
January 1991, Clinical and experimental rheumatology,
Copied contents to your clipboard!